{"id":"W2600855551","doi":"10.1200/jco.2013.31.15_suppl.5002","title":"Double-blind randomized trial of aflibercept versus placebo with docetaxel and prednisone for treatment of metastatic castration-resistant prostate cancer (mCRPC).","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Aflibercept; Medicine; Docetaxel; Placebo; Prednisone; Hazard ratio; Clinical endpoint; Internal medicine; Prostate cancer; Surgery; Bevacizumab; Randomized controlled trial; Urology; Oncology; Chemotherapy; Gastroenterology; Cancer; Confidence interval; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00403617,0.002917028,0.00512358,0.0007871553,0.000733862,0.001756333,0.001354325,0.003644655,0.01429103],"category_scores_gemma":[0.004211713,0.001322109,0.002291962,0.0006168472,0.002205838,0.001770193,0.000699129,0.003590961,0.002574484],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009472747,"about_ca_system_score_gemma":0.001584124,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009324058,"about_ca_topic_score_gemma":0.00168146,"domain_scores_codex":[0.9978803,0.001237282,0.0001532435,0.0003737177,0.0001105978,0.0002448987],"domain_scores_gemma":[0.9977909,0.0007332556,0.0005168531,0.0002000506,0.0001556794,0.0006032243],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9944394,0.001784726,0.00007084044,0.0002321398,0.0002238086,0.000007299299,0.00001062837,0.00006561042,0.0003749836,0.00004801677,0.0002303027,0.002512335],"study_design_scores_gemma":[0.9877528,0.01156036,0.0001404305,0.00001212225,0.00009411045,0.000005568126,0.000004057176,0.000132816,0.00006634145,0.00006618739,0.0001608911,0.000004450878],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9237933,0.0115719,0.003815432,0.002665654,0.006731001,0.03826516,0.004142564,0.0008056394,0.008209388],"genre_scores_gemma":[0.9496061,0.003383938,0.004617711,0.00298395,0.00206651,0.02616489,0.001801515,0.00007552213,0.009299836],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01429103,"threshold_uncertainty_score":0.04780823,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2490635725808365,"score_gpt":0.5163570845611213,"score_spread":0.2672935119802847,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}